Have a personal or library account? Click to login
Very long Detection Times after High and repeated intake of Heroin and Methadone, measured in Oral Fluid Cover

Very long Detection Times after High and repeated intake of Heroin and Methadone, measured in Oral Fluid

Open Access
|Mar 2015

References

  1. [1] Drummer, O.H., (2006) Drug testing in oral fluid. Clin Biochem Rev 27: 147-159.
  2. [2] Caplan, Y.H., Goldberger, B.A. (2001) Alternative specimens for workplace drug testing. J Anal Toxicol 25: 396-399.10.1093/jat/25.5.39611499896
  3. [3] Vindenes, V., Yttredal, B., Oiestad, E.L., Waal, H., Bernard, J.P., Morland, J.G. et al. (2011) Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine. J Anal Toxicol 35: 32-39.10.1093/anatox/35.1.3221219701
  4. [4] Heltsley, R., Depriest, A., Black, D.L., Crouch, D.J., Robert, T., Marshall, L. et al. (2012) Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens. J Anal Toxicol 36: 75-80.10.1093/jat/bkr01922337775
  5. [5] Oiestad, E.L., Johansen, U., Christophersen, A.S. (2007) Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin Chem 53: 300-309.10.1373/clinchem.2006.07423717158196
  6. [6] Langel, K., Gjerde, H., Favretto, D., Lillsunde, P., Oiestad, E.L., Ferrara, S.D. et al. (2013) Comparison of drug concentrations between whole blood and oral fluid. Drug Test. Anal.10.1002/dta.153224039237
  7. [7] Wille, S.M., Raes, E., Lillsunde, P., Gunnar, T., Laloup, M., Samyn, N. et al. (2009) Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit 31: 511-519.10.1097/FTD.0b013e3181ae46ea19571773
  8. [8] Kato, K., Hillsgrove, M., Weinhold, L., Gorelick, D.A., Darwin, W.D., Cone, E.J. (1993) Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions. J Anal Toxicol 17: 338-341.10.1093/jat/17.6.3388271779
  9. [9] Drummer, O.H., (2008) Introduction and review of collection techniques and applications of drug testing of oral fluid. Ther Drug Monit 30: 203-206.
  10. [10] Gray, T.R., Dams, R., Choo, R.E., Jones, H.E., Huestis, M.A. (2011) Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence. Forensic Sci Int 206: 98-102.10.1016/j.forsciint.2010.06.031301213420667673
  11. [11] Bosker, W.M., Huestis, M.A. (2009) Oral fluid testing for drugs of abuse. Clin Chem 55: 1910-1931.10.1373/clinchem.2008.108670316505419745062
  12. [12] Verstraete, A.G., (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26: 200-205.10.1097/00007691-200404000-0002015228165
  13. [13] Presley, L., Lehrer, M., Seiter, W., Hahn, D., Rowland, B., Smith, M. et al. (2003) High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens. Forensic Sci Int 133: 22-25.10.1016/S0379-0738(03)00045-8
  14. [14] Cone, E.J., Welch, P., Paul, B.D., Mitchell, J.M. (1991) Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration. J Anal. Toxicol. 15: 161-166.
  15. [15] Dams, R., Choo, R.E., Lambert, W.E., Jones, H., Huestis, M.A. (2007) Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug and Alcohol Dependence 87: 258-267.10.1016/j.drugalcdep.2006.08.020
  16. [16] Jenkins, A.J., Oyler, J.M., Cone, E.J. (1995) Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol 19: 359-374.10.1093/jat/19.6.359
  17. [17] Goldberger, B.A., Darwin, W.D., Grant, T.M., Allen, A.C., Caplan, Y.H., Cone, E.J. (1993) Measurement of heroin and its metabolites by isotope-dilution electronimpact mass spectrometry. Clin Chem 39: 670-675.10.1093/clinchem/39.4.670
  18. [18] Wang, W.L., Darwin, W.D., Cone, E.J. (1994) Simultaneous assay of cocaine, heroin and metabolites in hair, plasma, saliva and urine by gas chromatography-mass spectrometry. J Chromatogr. B Biomed. Appl 660: 279-290.
  19. [19] Kim, I., Barnes, A.J., Oyler, J.M., Schepers, R., Joseph, R.E., Jr., Cone, E.J. et al. (2002) Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem 48: 1486-1496.10.1093/clinchem/48.9.1486
  20. [20] Bernard, J.P., Morland, J., Krogh, M., Khiabani, H.Z. (2009) Methadone and impairment in apprehended drivers. Addiction 104: 457-464.10.1111/j.1360-0443.2008.02470.x
  21. [21] Chikhi-Chorfi, N., Pham-Huy, C., Galons, H., Manuel, N., Lowenstein, W., Warnet, J.M. et al. (1998) Rapid determination of methadone and its major metabolite in biological fluids by gas-liquid chromatography with thermionic detection for maintenance treatment of opiate addicts. J Chromatogr. B Biomed. Sci Appl 718: 278-284.10.1016/S0378-4347(98)00375-2
  22. [22] Shiran, M.R., Hassanzadeh-Khayyat, M., Iqbal, M.Z., Lagundoye, O., Seivewright, N., Lennard, M.S. et al. (2005) Can saliva replace plasma for the monitoring of methadone? Ther Drug Monit 27: 580-586.10.1097/01.ftd.0000164392.01779.db16175130
  23. [23] Vindenes, V., Jordbru, D., Knapskog, A.B., Kvan, E., Mathisrud, G., Slordal, L. et al. (2012) Impairment based legislative limits for driving under the influence of nonalcohol drugs in Norway. Forensic Sci Int 219: 1-11.10.1016/j.forsciint.2011.11.00422118917
  24. [24] Laloup, M., Del Mar Ramirez, F.M., Wood, M., De, B.G., Maes, V., Samyn, N. (2006) Correlation of Delta9-tetrahydrocannabinol concentrations determined by LCMS- MS in oral fluid and plasma from impaired drivers and evaluation of the onsite Drager DrugTest. Forensic Sci Int 161: 175-179.10.1016/j.forsciint.2006.03.03316842950
  25. [25] Cone, E.J., Clarke, J., Tsanaclis, L. (2007) Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. J Anal Toxicol 31: 424-433.10.1093/jat/31.8.42417988455
  26. [26] Gjerde, H., Christophersen, A.S., Normann, P.T., Assum, T., Oiestad, E.L., Morland, J. (2013) Norwegian roadside survey of alcohol and drug use by drivers (2008-2009). Traffic. Inj. Prev. 14: 443-452.
  27. [27] Lund, H.M., Oiestad, E.L., Gjerde, H., Christophersen, A.S. (2011) Drugs of abuse in oral fluid collected by two different sample kits--stability testing and validation using ultra performance tandem mass spectrometry analysis. J Chromatogr. B Analyt. Technol Biomed. Life Sci 879: 3367-3377.
  28. [28] Berg, T., Lundanes, E., Christophersen, A.S., Strand, D.H. (2009) Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC-MS/ MS. J Chromatogr. B Analyt. Technol Biomed. Life Sci 877: 421-432.
  29. [29] Hegstad, S., Khiabani, H.Z., Oiestad, E.L., Berg, T., Christophersen, A.S. (2007) Rapid quantification of buprenorphine-glucuronide and norbuprenorphineglucuronide in human urine by LC-MS-MS. J Anal Toxicol 31: 214-219.10.1093/jat/31.4.21417555645
  30. [30] Oiestad, E.L., Johansen, U., Oiestad, A.M., Christophersen, A.S. (2011) Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol 35: 280-293.10.1093/anatox/35.5.28021619723
  31. [31] Karinen, R., Andersen, J.M., Ripel, A., Hasvold, I., Hopen, A.B., Morland, J. et al. (2009) Determination of heroin and its main metabolites in small sample volumes of whole blood and brain tissue by reversed-phase liquid chromatographytandem mass spectrometry. J Anal Toxicol 33: 345-350.10.1093/jat/33.7.34519796503
  32. [32] Øiestad EL, Johansen U, and et al. Determination of synthetic cannabinoids in oral fluid with ultra performance tandem mass spectrometry UPLC-MS/MS. TIAFT Hamamatsu 2012. P-187. 2012. Ref Type: Conference Proceeding
  33. [33] Cone, E.J., Huestis, M.A. (2007) Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad. Sci 1098: 51-103.
  34. [34] Phillips, S.G., Allen, K.R. (2006) Acetylcodeine as a marker of illicit heroin abuse in oral fluid samples. J Anal Toxicol 30: 370-374.10.1093/jat/30.6.37016872567
  35. [35] Toennes, S.W., Steinmeyer, S., Maurer, H.J., Moeller, M.R., Kauert, G.F. (2005) Screening for drugs of abuse in oral fluid--correlation of analysis results with serum in forensic cases. J Anal Toxicol 29: 22-27.10.1093/jat/29.1.2215808009
  36. [36] Lee, D., Milman, G., Barnes, A.J., Goodwin, R.S., Hirvonen, J., Huestis, M.A. (2011) Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Clin Chem 57: 1127-1136.10.1373/clinchem.2011.16482221677094
  37. [37] Smith-Kielland, A., Skuterud, B., Morland, J. (1999) Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal. Toxicol. 23: 323-332.
Language: English
Page range: 34 - 41
Published on: Mar 3, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2015 V. Vindenes, A. Enger, K. Nordal, U. Johansen, A.S. Christophersen, E.L. Øiestad, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.